These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 22993593)

  • 1. Insulin resistance derived from zinc deficiency in non-diabetic patients with chronic hepatitis C.
    Himoto T; Yoneyama H; Deguch A; Kurokohchi K; Inukai M; Masugata H; Goda F; Senda S; Watanabe S; Kubota S; Kuriyama S; Masaki T
    Exp Ther Med; 2010 Jul; 1(4):707-711. PubMed ID: 22993593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exacerbation of insulin resistance and hepatic steatosis deriving from zinc deficiency in patients with HCV-related chronic liver disease.
    Himoto T; Nomura T; Tani J; Miyoshi H; Morishita A; Yoneyama H; Haba R; Masugata H; Masaki T
    Biol Trace Elem Res; 2015 Feb; 163(1-2):81-8. PubMed ID: 25413880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin resistance/beta-cell function and serum ferritin level in non-diabetic patients with hepatitis C virus infection.
    Furutani M; Nakashima T; Sumida Y; Hirohama A; Yoh T; Kakisaka Y; Mitsuyoshi H; Senmaru H; Okanoue T
    Liver Int; 2003 Aug; 23(4):294-9. PubMed ID: 12895270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic iron accumulation may be associated with insulin resistance in patients with chronic hepatitis C.
    Sumida Y; Kanemasa K; Fukumoto K; Yoshida N; Sakai K
    Hepatol Res; 2007 Nov; 37(11):932-40. PubMed ID: 17854465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selenium deficiency is associated with insulin resistance in patients with hepatitis C virus-related chronic liver disease.
    Himoto T; Yoneyama H; Kurokohchi K; Inukai M; Masugata H; Goda F; Haba R; Watababe S; Kubota S; Senda S; Masaki T
    Nutr Res; 2011 Nov; 31(11):829-35. PubMed ID: 22118753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relation of serum insulin-like growth factor-1 (IGF-1) levels with hepatitis C virus infection and insulin resistance.
    Helaly GF; Hussein NG; Refai W; Ibrahim M
    Transl Res; 2011 Sep; 158(3):155-62. PubMed ID: 21867981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of zinc deficiency to insulin resistance in patients with primary biliary cirrhosis.
    Himoto T; Yoneyama H; Kurokochi K; Inukai M; Masugata H; Goda F; Haba R; Watanabe S; Senda S; Masaki T
    Biol Trace Elem Res; 2011 Dec; 144(1-3):133-42. PubMed ID: 21476007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin resistance and hepatitis C virus: a case-control study of non-obese, non-alcoholic and non-steatotic hepatitis virus carriers with persistently normal serum aminotransferase.
    Tanaka N; Nagaya T; Komatsu M; Horiuchi A; Tsuruta G; Shirakawa H; Umemura T; Ichijo T; Matsumoto A; Yoshizawa K; Aoyama T; Kiyosawa K; Tanaka E
    Liver Int; 2008 Sep; 28(8):1104-11. PubMed ID: 18397231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of hepatitis C virus infection on insulin resistance in chronic haemodialysis patients.
    Ozdemir A; Yalinbas B; Selamet U; Eres M; Turkmen F; Kumbasar F; Murat B; Keskin AT; Barut Y
    Yonsei Med J; 2007 Apr; 48(2):274-80. PubMed ID: 17461527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations between Zinc Deficiency and Metabolic Abnormalities in Patients with Chronic Liver Disease.
    Himoto T; Masaki T
    Nutrients; 2018 Jan; 10(1):. PubMed ID: 29342898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ratio of insulin-like growth factor-I/insulin-like growth factor-binding protein-3 in sera of patients with hepatitis C virus-related chronic liver disease as a predictive marker of insulin resistance.
    Himoto T; Tani J; Miyoshi H; Yoneyama H; Mori H; Inukai M; Masugata H; Goda F; Senda S; Haba R; Masaki T
    Nutr Res; 2013 Jan; 33(1):27-33. PubMed ID: 23351407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic steatosis and insulin resistance are associated with serum imbalance of adiponectin/tumour necrosis factor-alpha in chronic hepatitis C patients.
    Durante-Mangoni E; Zampino R; Marrone A; Tripodi MF; Rinaldi L; Restivo L; Cioffi M; Ruggiero G; Adinolfi LE
    Aliment Pharmacol Ther; 2006 Nov; 24(9):1349-57. PubMed ID: 17059516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of zinc administration in patients with hepatitis C virus-related chronic liver disease.
    Himoto T; Hosomi N; Nakai S; Deguchi A; Kinekawa F; Matsuki M; Yachida M; Masaki T; Kurokochi K; Watanabe S; Senda S; Kuriyama S
    Scand J Gastroenterol; 2007 Sep; 42(9):1078-87. PubMed ID: 17710674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic hepatitis C infection is associated with insulin resistance and lipid profiles.
    Dai CY; Yeh ML; Huang CF; Hou CH; Hsieh MY; Huang JF; Lin IL; Lin ZY; Chen SC; Wang LY; Chuang WL; Yu ML; Tung HD
    J Gastroenterol Hepatol; 2015 May; 30(5):879-84. PubMed ID: 23808794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adiponectin levels and insulin resistance among patients with chronic hepatitis C.
    Carvalho RF; Atta AM; de Oliveira IS; Santos TPS; Santos JPA; Schinoni MI; de Sousa-Atta MLB
    Acta Trop; 2018 Feb; 178():258-263. PubMed ID: 29217381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C virus clearance by direct-acting antiviral treatments and impact on insulin resistance in chronic hepatitis C patients.
    Adinolfi LE; Nevola R; Guerrera B; D'Alterio G; Marrone A; Giordano M; Rinaldi L
    J Gastroenterol Hepatol; 2018 Jul; 33(7):1379-1382. PubMed ID: 29228501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study on the relationship between insulin growth factor 1 and liver fibrosis in patients with chronic hepatitis C with type 2 diabetes mellitus.
    Cao LH; Lu FM; Lu XJ; Zhu LY
    J Cell Biochem; 2018 Nov; 119(11):9513-9518. PubMed ID: 30105830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proinflammatory cytokines, insulin resistance, and insulin secretion in chronic hepatitis C patients: A case-control study.
    Lecube A; Hernández C; Genescà J; Simó R
    Diabetes Care; 2006 May; 29(5):1096-101. PubMed ID: 16644643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of serum zinc levels with pathological and laboratory findings in patients with nonalcoholic fatty liver disease.
    Ito T; Ishigami M; Ishizu Y; Kuzuya T; Honda T; Ishikawa T; Toyoda H; Kumada T; Fujishiro M
    Eur J Gastroenterol Hepatol; 2020 Jun; 32(6):748-753. PubMed ID: 31688305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of soy protein supplementation in patients with chronic hepatitis C: a randomized clinical trial.
    Oliveira LP; de Jesus RP; Boulhosa RS; Mendes CM; Gnoatto MC; Lemaire DC; Toralles MB; Cavalcante LN; Lyra AC; Lyra LG
    World J Gastroenterol; 2012 May; 18(18):2203-11. PubMed ID: 22611313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.